Biomaterials for tissue engineering applications

Seminars in Pediatric Surgery

Volumn 23, Issue 3, 2014, Pages 112-118

  Keane, Timothy J ^a,b   Badylak, Stephen F ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bioactive molecules; Biomaterials; Tissue engineering

Indexed keywords

BIOMATERIAL; TISSUE SCAFFOLD;

ARTICLE; BIOENGINEERING; HUMAN; MATERIALS TESTING; NONHUMAN; PEDIATRIC SURGERY; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE GROWTH; ARTIFICIAL SKIN; CHILD; PEDIATRICS; PROCEDURES; TISSUE SCAFFOLD;

BIOCOMPATIBLE MATERIALS; CHILD; HUMANS; PEDIATRICS; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84903472724     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2014.06.010     Document Type: Article

References (133)

1. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260(5110):920-926.
2. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30(30):5897-5909.
3. Scott J.E. Extracellular matrix, supramolecular organisation and shape. J Anat 1995, 187(Pt 2):259-269.
4. Nelson C.M., Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006, 22:287-309.
5. Fata J.E., Werb Z., Bissell M.J. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 2004, 6(1):1-11.
6. Huttenlocher A., Sandborg R.R., Horwitz A.F. Adhesion in cell migration. Curr Opin Cell Biol 1995, 7(5):697-706.
7. Humphries M.J., Newham P. The structure of cell-adhesion molecules. Trends Cell Biol 1998, 8(2):78-83.
8. Cohen M., Joester D., Geiger B., Addadi L. Spatial and temporal sequence of events in cell adhesion: from molecular recognition to focal adhesion assembly. Chembiochem 2004, 5(10):1393-1399.
9. Badylak S., Kokini K., Tullius B., Whitson B. Strength over time of a resorbable bioscaffold for body wall repair in a dog model. J Surg Res 2001, 99(2):282-287.
10. Mann B.K., Gobin A.S., Tsai A.T., Schmedlen R.H., West J.L. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 2001, 22(22):3045-3051.
11. Mann B.K., West J.L. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 2002, 60(1):86-93.
12. Liu Tsang V., Chen A.A., Cho L.M., et al. Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J 2007, 21(3):790-801.
13. Schmidt D.R., Kao W.J. Monocyte activation in response to polyethylene glycol hydrogels grafted with RGD and PHSRN separated by interpositional spacers of various lengths. J Biomed Mater Res A 2007, 83(3):617-625.
14. Fittkau M.H., Zilla P., Bezuidenhout D., et al. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials 2005, 26(2):167-174.
15. Hynd M.R., Frampton J.P., Dowell-Mesfin N., Turner J.N., Shain W. Directed cell growth on protein-functionalized hydrogel surfaces. J Neurosci Methods 2007, 162(1-2):255-263.
16. Weber L.M., Anseth K.S. Hydrogel encapsulation environments functionalized with extracellular matrix interactions increase islet insulin secretion. Matrix Biol 2008, 27(8):667-673.
17. Weber L.M., Hayda K.N., Haskins K., Anseth K.S. The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 2007, 28(19):3004-3011.
18. Mann B.K., Tsai A.T., Scott-Burden T., West J.L. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials 1999, 20(23-24):2281-2286.
19. Saha K., Irwin E.F., Kozhukh J., Schaffer D.V., Healy K.E. Biomimetic interfacial interpenetrating polymer networks control neural stem cell behavior. J Biomed Mater Res A 2007, 81(1):240-249.
20. Liu S.Q., Ee P.L., Ke C.Y., Hedrick J.L., Yang Y.Y. Biodegradable poly(ethylene glycol)-peptide hydrogels with well-defined structure and properties for cell delivery. Biomaterials 2009, 30(8):1453-1461.
21. Herten M., Jung R.E., Ferrari D., et al. Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats. Clin Oral Implants Res 2009, 20(2):116-125.
22. Salinas C.N., Anseth K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 2008, 29(15):2370-2377.
23. DeForest C.A., Polizzotti B.D., Anseth K.S. Sequential click reactions for synthesizing and patterning three-dimensional cell microenvironments. Nat Mater 2009, 8(8):659-664.
24. Zhu J., Tang C., Kottke-Marchant K., Marchant R.E. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides. Bioconjug Chem 2009, 20(2):333-339.
25. Lutolf M.P., Weber F.E., Schmoekel H.G., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21(5):513-518.
26. Mann B.K., Schmedlen R.H., West J.L. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 2001, 22(5):439-444.
27. Gobin A.S., West J.L. Val-ala-pro-gly, an elastin-derived non-integrin ligand: smooth muscle cell adhesion and specificity. J Biomed Mater Res A 2003, 67(1):255-259.
28. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24(24):4385-4415.
29. Ruoslahti E. The RGD story: a personal account. Matrix Biol 2003, 22(6):459-465.
30. Romano N.H., Sengupta D., Chung C., Heilshorn S.C. Protein-engineered biomaterials: nanoscale mimics of the extracellular matrix. Biochim Biophys Acta 2011, 1810(3):339-349.
31. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A 2003, 100(9):5413-5418.
32. Lee S.H., Miller J.S., Moon J.J., West J.L. Proteolytically degradable hydrogels with a fluorogenic substrate for studies of cellular proteolytic activity and migration. Biotechnol Prog 2005, 21(6):1736-1741.
33. Pratt A.B., Weber F.E., Schmoekel H.G., Muller R., Hubbell J.A. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng 2004, 86(1):27-36.
34. Raeber G.P., Lutolf M.P., Hubbell J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005, 89(2):1374-1388.
35. Kraehenbuehl T.P., Zammaretti P., Van der Vlies A.J., et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008, 29(18):2757-2766.
36. Raeber G.P., Lutolf M.P., Hubbell J.A. Mechanisms of 3-D migration and matrix remodeling of fibroblasts within artificial ECMs. Acta Biomater 2007, 3(5):615-629.
37. Patel P.N., Gobin A.S., West J.L., Patrick C.W. Poly(ethylene glycol) hydrogel system supports preadipocyte viability, adhesion, and proliferation. Tissue Eng 2005, 11(9-10):1498-1505.
38. Lee S.H., Moon J.J., Miller J.S., West J.L. Poly(ethylene glycol) hydrogels conjugated with a collagenase-sensitive fluorogenic substrate to visualize collagenase activity during three-dimensional cell migration. Biomaterials 2007, 28(20):3163-3170.
39. Gobin A.S., West J.L. Effects of epidermal growth factor on fibroblast migration through biomimetic hydrogels. Biotechnol Prog 2003, 19(6):1781-1785.
40. Aimetti A.A., Tibbitt M.W., Anseth K.S. Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels. Biomacromolecules 2009, 10(6):1484-1489.
41. Midha R., Munro C.A., Dalton P.D., Tator C.H., Shoichet M.S. Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J Neurosurg 2003, 99(3):555-565.
42. Lee A.C., Yu V.M., Lowe J.B., et al. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 2003, 184(1):295-303.
43. DeLong S.A., Moon J.J., West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005, 26(16):3227-3234.
44. He X., Ma J., Jabbari E. Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. Langmuir 2008, 24(21):12508-12516.
45. Schmoekel H.G., Weber F.E., Schense J.C., Gratz K.W., Schawalder P., Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 2005, 89(3):253-262.
46. Silva E.A., Kim E.S., Kong H.J., Mooney D.J. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 2008, 105(38):14347-14352.
47. den Braber E.T., de Ruijter J.E., Ginsel L.A., von Recum A.F., Jansen J.A. Orientation of ECM protein deposition, fibroblast cytoskeleton, and attachment complex components on silicone microgrooved surfaces. J Biomed Mater Res 1998, 40(2):291-300.
48. Yim E.K., Reano R.M., Pang S.W., Yee A.F., Chen C.S., Leong K.W. Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials 2005, 26(26):5405-5413.
49. Dalby M.J., Biggs M.J., Gadegaard N., Kalna G., Wilkinson C.D., Curtis A.S. Nanotopographical stimulation of mechanotransduction and changes in interphase centromere positioning. J Cell Biochem 2007, 100(2):326-338.
50. Gaubert H.E., Frey W. Highly parallel fabrication of nanopatterned surfaces with nanoscale orthogonal biofunctionalization imprint lithography. Nanotechnology 2007, 18(13):135101.
51. Champion J.A., Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A 2006, 103(13):4930-4934.
52. Champion J.A., Katare Y.K., Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc Natl Acad Sci U S A 2007, 104(29):11901-11904.
53. Rolland J.P., Maynor B.W., Euliss L.E., Exner A.E., Denison G.M., DeSimone J.M. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc 2005, 127(28):10096-10100.
54. Euliss L.E., DuPont J.A., Gratton S., DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev 2006, 35(11):1095-1104.
55. Geng Y., Dalhaimer P., Cai S., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007, 2(4):249-255.
56. Barradas A.M., Lachmann K., Hlawacek G., et al. Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells. Acta Biomater 2012, 8(8):2969-2977.
57. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276(5317):1425-1428.
58. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004, 6(4):483-495.
59. Rehfeldt F., Engler A.J., Eckhardt A., Ahmed F., Discher D.E. Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery. Adv Drug Deliv Rev 2007, 59(13):1329-1339.
60. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126(4):677-689.
61. Beningo K.A., Wang Y.L. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci 2002, 115(Pt 4):849-856.
62. van den Dries K., van Helden S.F., Riet J., et al. Geometry sensing by dendritic cells dictates spatial organization and PGE(2)-induced dissolution of podosomes. Cell Mol Life Sci 2012, 69(11):1889-1901.
63. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat Mater 2009, 8(1):15-23.
64. Badylak S.F., Taylor D., Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011, 13:27-53.
65. Courtman D.W., Pereira C.A., Kashef V., McComb D., Lee J.M., Wilson G.J. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994, 28(6):655-666.
66. Schmidt C.E., Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000, 21(22):2215-2231.
67. Dahl S.L., Koh J., Prabhakar V., Niklason L.E. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003, 12(6):659-666.
68. Conklin B.S., Richter E.R., Kreutziger K.L., Zhong D.S., Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002, 24(3):173-183.
69. Badylak S., Liang A., Record R., Tullius R., Hodde J. Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold. Biomaterials 1999, 20(23-24):2257-2263.
70. Badylak S.F., Lantz G.C., Coffey A., Geddes L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989, 47(1):74-80.
71. Remlinger N.T., Czajka C.A., Juhas M.E., et al. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction. Biomaterials 2010, 31(13):3520-3526.
72. Gilbert T.W., Gilbert S., Madden M., Reynolds S.D., Badylak S.F. Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann Thorac Surg 2008, (3):967-974. [discussion 967-74].
73. French K.M., Boopathy A.V., DeQuach J.A., et al. A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater 2012.
74. Wainwright J.M., Hashizume R., Fujimoto K.L., et al. Right ventricular outflow tract repair with a cardiac biologic scaffold. Cells Tissues Organs 2012, 195(1-2):159-170.
75. Robinson K.A., Li J., Mathison M., et al. Extracellular matrix scaffold for cardiac repair. Circulation 2005, 112(9 Suppl):I135-I143.
76. Seif-Naraghi S.B., Singelyn J.M., Salvatore M.A., et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med 2013, 5(173):173ra25.
77. Valentin J.E., Turner N.J., Gilbert T.W., Badylak S.F. Functional skeletal muscle formation with a biologic scaffold. Biomaterials 2010, 31(29):7475-7484.
78. Mase V.J., Hsu J.R., Wolf S.E., et al. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 2010, 33(7):511.
79. Badylak S.F., Hoppo T., Nieponice A., Gilbert T.W., Davison J.M., Jobe B.A. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 2011, 17(11-12):1643-1650.
80. Badylak S.F., Vorp D.A., Spievack A.R., et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 2005, 128(1):87-97.
81. Nieponice A., Gilbert T.W., Badylak S.F. Reinforcement of esophageal anastomoses with an extracellular matrix scaffold in a canine model. Ann Thorac Surg 2006, 82(6):2050-2058.
82. Nieponice A., McGrath K., Qureshi I., et al. An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 2009, 69(2):289-296.
83. Hoppo T., Badylak S.F., Jobe B.A. A novel esophageal-preserving approach to treat high-grade dysplasia and superficial adenocarcinoma in the presence of chronic gastroesophageal reflux disease. World J Surg 2012.
84. Uygun B.E., Soto-Gutierrez A., Yagi H., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16(7):814-820.
85. Lin P., Chan W.C., Badylak S.F., Bhatia S.N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng 2004, 10(7-8):1046-1053.
86. Petersen T.H., Calle E.A., Zhao L., et al. Tissue-engineered lungs for in vivo implantation. Science 2010, 329(5991):538-541.
87. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009, 5(1):1-13.
88. Hodde J.P., Record R.D., Liang H.A., Badylak S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 2001, 8(1):11-24.
89. Voytik-Harbin S.L., Brightman A.O., Kraine M.R., Waisner B., Badylak S.F. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997, 67(4):478-491.
90. Hodde J.P., Badylak S.F., Brightman A.O., Voytik-Harbin S.L. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng 1996, 2(3):209-217.
91. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32(12):3233-3243.
92. Keane T.J., Londono R., Turner N.J., Badylak S.F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012, 33(6):1771-1781.
93. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
94. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32(28):6692-6709.
95. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011, 11(11):750-761.
96. Porcheray F., Viaud S., Rimaniol A.C., et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142(3):481-489.
97. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005, 175(1):342-349.
98. Stout R.D., Watkins S.K., Suttles J. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J Leukoc Biol 2009, 86(5):1105-1109.
99. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 2009, 15(7):1687-1694.
100. Tidball J.G., Villalta S.A. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010, 298(5):R1173-R1187.
101. Collie A.M., Bota P.C., Johns R.E., Maier R.V., Stayton P.S. Differential monocyte/macrophage interleukin-1beta production due to biomaterial topography requires the beta2 integrin signaling pathway. J Biomed Mater Res A 2011, 96(1):162-169.
102. Bota P.C., Collie A.M., Puolakkainen P., et al. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res A 2010, 95(2):649-657.
103. Fukano Y., Usui M.L., Underwood R.A., et al. Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice. J Biomed Mater Res A 2010, 94(4):1172-1186.
104. Underwood R.A., Usui M.L., Zhao G., et al. Quantifying the effect of pore size and surface treatment on epidermal incorporation into percutaneously implanted sphere-templated porous biomaterials in mice. J Biomed Mater Res A 2011, 98(4):499-508.
105. Madden L.R., Mortisen D.J., Sussman E.M., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 2010, 107(34):15211-15216.
106. Mokarram N., Merchant A., Mukhatyar V., Patel G., Bellamkonda R.V. Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials 2012, 33(34):8793-8801.
107. Franz S., Allenstein F., Kajahn J., et al. Artificial extracellular matrices composed of collagen I and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages. Acta Biomater 2012.
108. Brown B.N., Badylak S.F. Expanded applications, shifting paradigms and an improved understanding of host-biomaterial interactions. Acta Biomater 2013, 9(2):4948-4955.
109. Agrawal V., Johnson S.A., Reing J., et al. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc Natl Acad Sci U S A 2010, 107(8):3351-3355.
110. Nieponice A., Gilbert T.W., Johnson S.A., Turner N.J., Badylak S.F. Bone marrow-derived cells participate in the long-term remodeling in a mouse model of esophageal reconstruction. J Surg Res 2012.
111. Tottey S., Corselli M., Jeffries E.M., Londono R., Peault B., Badylak S.F. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 2011, 17(1-2):37-44.
112. Boruch A.V., Nieponice A., Qureshi I.R., Gilbert T.W., Badylak S.F. Constructive remodeling of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a canine partial cystectomy model. J Surg Res 2010, 161(2):217-225.
113. Ambrosio F., Wolf S.L., Delitto A., et al. The emerging relationship between regenerative medicine and physical therapeutics. Phys Ther 2010, 90(12):1807-1814.
114. Saxena A.K. Tissue engineering and regenerative medicine research perspectives for pediatric surgery. Pediatr Surg Int 2010, 26(6):557-573.
115. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007, 2008, U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation: Rockville, MD.
116. Eurotransplant International Foundation Annual Report 2008, ed. A. Oosterlee and A. Rahmel2008, Leiden, The Netherlands: Eurotransplant Intl Foundation.
117. Giovanelli M., Gupte G.L., McKiernan P., et al. Impact of change in the United Kingdom pediatric donor organ allocation policy for intestinal transplantation. Transplantation 2009, 87(11):1695-1699.
118. Tiao G.M., Alonso M.H., Ryckman F.C. Pediatric liver transplantation. Semin Pediatr Surg 2006, 15(3):218-227.
119. Harada K.M., Mandia-Sampaio E.L., de Sandes-Freitas T.V., et al. Risk factors associated with graft loss and patient survival after kidney transplantation. Transplant Proc 2009, 41(9):3667-3670.
120. Reding R. Long-term complications of immunosuppression in pediatric liver recipients. Acta Gastroenterol Belg 2005, 68(4):453-456.
121. Magee J.C., Krishnan S.M., Benfield M.R., Hsu D.T., Shneider B.L. Pediatric transplantation in the United States, 1997-2006. Am J Transplant 2008, 8(4 Pt 2):935-945.
122. Arul G.S., Parikh D. Oesophageal replacement in children. Ann R Coll Surg Engl 2008, 90(1):7-12.
123. Gallo G., Zwaveling S., Groen H., Van der Zee D., Hulscher J. Long-gap esophageal atresia: a meta-analysis of jejunal interposition, colon interposition, and gastric pull-up. Eur J Pediatr Surg 2012, 22(6):420-425.
124. Patel M., Fisher J.P. Biomaterial scaffolds in pediatric tissue engineering. Pediatr Res 2008, 63(5):497-501.
125. Gravante G., Delogu D., Giordan N., Morano G., Montone A., Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res 2007, 28(2):269-274.
126. Cass D.L., Meuli M., Adzick N.S. Scar wars: implications of fetal wound healing for the pediatric burn patient. Pediatr Surg Int 1997, 12(7):484-489.
127. De Buys Roessingh A.S., Hohlfeld J., Scaletta C., et al. Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant 2006, 15(8-9):823-834.
128. Hohlfeld J., de Buys Roessingh A., Hirt-Burri N., et al. Tissue engineered fetal skin constructs for paediatric burns. Lancet 2005, 366(9488):840-842.
129. Hibino N., McGillicuddy E., Matsumura G., et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010, 139(2):431-436. [436 e1-2].
130. Moreau J.L., Caccamese J.F., Coletti D.P., Sauk J.J., Fisher J.P. Tissue engineering solutions for cleft palates. J Oral Maxillofac Surg 2007, 65(12):2503-2511.
131. Paganelli C., Fontana P., Porta F., Majorana A., Pazzaglia U.E., Sapelli P.L. Indications on suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate. J Oral Rehabil 2006, 33(8):625-629.
132. Velardi F., Amante P.R., Caniglia M., et al. Osteogenesis induced by autologous bone marrow cells transplant in the pediatric skull. Childs Nerv Syst 2006, 22(9):1158-1166.
133. Elliott M.J., De Coppi P., Speggiorin S., et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 2012, 380(9846):994-1000.